SFJ Pharmaceuticals, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SFJ Pharmaceuticals, Inc. - overview
Established
2009
Location
Pleasanton, CA, US
Primary Industry
Pharmaceuticals
About
Based in California, US, and founded by Robert DeBenedetto (President and CEO) in 2009, SFJ (Strategic Funding and Joint-Development) Pharmaceuticals, Inc. also known as SFJ-NSCLC, operates as a pharmaceutical company that engages in the clinical development and registration of pharmaceutical products. In March 2009, the firm raised USD 45 million in series A financing co-led by Abingworth Management and Clarus Ventures, and in October 2013, it raised USD 30 million in venture funding led by new investor Clarus Ventures. The company is also backed by Blackstone.
The strategic funding and joint-development company provide risk capital, expertise, resources, and global reach for accelerated clinical development and registration of pharmaceutical products. The company through its partners in the biopharmaceutical industry, focuses on filling operational and funding gaps and maximizing the retained net present value (NPV) for late-stage partnerships. SFJ’s solution encompasses three key pillars: capital, expertise, and resources. SFJ brings multiple approvals in major markets, trial design and execution capabilities, and incremental headcount to support its collaborations.
Additionally, the company offers global reach and manages contract research organizations (CROs) for full-service support.
Current Investors
Clarus Ventures, Abingworth
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.sfj-pharma.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.